Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 8, 2007 - Issue 12
Submit an article Journal homepage
1,664
Views
76
CrossRef citations to date
0
Altmetric
Drug Evaluation

PEG-asparaginase

Cecilia H Fu Childrens Hospital Los Angeles, Division of Hematology/Oncology, Los Angeles, CA, USA
&
Kathleen M Sakamoto Mattel Children's Hospital, Divison of Hematology-Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Pages 1977-1984 | Published online: 14 Aug 2007

Citations (76)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (9)

Awol Mekonnen Ali, Haileyesus Adam, Daniel Hailu, Rawleigh Howe, Teferra Abula & Marieke JH Coenen. (2023) Evaluating the Frequencies of CNOT3, GRIA1, NFATC2, and PNPLA3 Variant Alleles and Their Association with L-Asparaginase Hypersensitivity in Pediatric Acute Lymphoblastic Leukemia in Addis Ababa, Ethiopia. The Application of Clinical Genetics 16, pages 131-137.
Read now
Xavier Thomas & Caroline Le Jeune. (2016) Treating adults with acute lymphocytic leukemia: new pharmacotherapy options. Expert Opinion on Pharmacotherapy 17:17, pages 2319-2330.
Read now
Françoise Huguet, Thibaut Leguay, Emmanuel Raffoux, Philippe Rousselot, Norbert Vey, Arnaud Pigneux, Norbert Ifrah & Hervé Dombret. (2015) Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup. Leukemia & Lymphoma 56:4, pages 847-857.
Read now
Michael E Rytting. (2012) Role of L-asparaginase in acute lymphoblastic leukemia: focus on adult patients. Blood and Lymphatic Cancer: Targets and Therapy 2, pages 117-124.
Read now
Wanda Salzer, Nita Seibel & Malcolm Smith. (2012) Erwinia asparaginase in pediatric acute lymphoblastic leukemia. Expert Opinion on Biological Therapy 12:10, pages 1407-1414.
Read now
Henk van den Berg. (2011) Asparaginase revisited. Leukemia & Lymphoma 52:2, pages 168-178.
Read now
Michael Rytting. (2010) Peg-asparaginase for acute lymphoblastic leukemia. Expert Opinion on Biological Therapy 10:5, pages 833-839.
Read now
Riccardo Masetti & Andrea Pession. (2009) First-line treatment of acute lymphoblastic leukemia with pegasparaginase. Biologics: Targets and Therapy 3, pages 359-368.
Read now
Amer Zeidan, Eunice S Wang & Meir Wetzler. (2009) Pegasparaginase: where do we stand?. Expert Opinion on Biological Therapy 9:1, pages 111-119.
Read now

Articles from other publishers (67)

Sherif A. Gaballa, Taro Shimizu, Hidenori Ando, Haruka Takata, Sherif E. Emam, Eslam Ramadan, Youssef W. Naguib, Fatma M. Mady, Khaled A. Khaled & Tatsuhiro Ishida. (2023) Treatment-induced and Pre-existing Anti-peg Antibodies: Prevalence, Clinical Implications, and Future Perspectives. Journal of Pharmaceutical Sciences.
Crossref
Mary Jiang & Alexandra Ahmet. (2023) Hypoglycemia during treatment of acute lymphoblastic leukemia. Paediatrics & Child Health 28:5, pages 305-306.
Crossref
Archana Sharma, Vineeta Kaushik & Manisha Goel. (2022) Insights into the Distribution and Functional Properties of l -Asparaginase in the Archaeal Domain and Characterization of Picrophilus torridus Asparaginase Belonging to the Novel Family Asp2like1 . ACS Omega 7:45, pages 40750-40765.
Crossref
S. S. Alexandrova, Y. A. Gladilina, M. V. Pokrovskaya, N. N. Sokolov & D. D. Zhdanov. (2022) Mechanisms of Development of Side Effects and Drug Resistance to Asparaginase and Ways to Overcome Them. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 16:3, pages 175-186.
Crossref
Rajashekar Sindhu & Haravey K. Manonmani. (2022) L-asparaginase-mediated Therapy in L-asparagine Auxotrophic Cancers: A Review. Anti-Cancer Agents in Medicinal Chemistry 22:13, pages 2393-2410.
Crossref
Adriana Krupa, Johan de Vos, Lynn Van Eetvelde & Erik Teske. (2022) Pegylated asparaginase in feline high-grade lymphoma: clinical results of single injection and continued incorporation into a modified COP regimen. Journal of Feline Medicine and Surgery 24:8, pages e203-e213.
Crossref
Akmal M. Asrorov, Bahtiyor Muhitdinov, Bin Tu, Sharafitdin Mirzaakhmedov, Huiyuan Wang & Yongzhuo Huang. (2022) Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents. Molecules 27:12, pages 3836.
Crossref
Xiaopei Zhang, Xinyuan Zhu & Yunfeng Lu. (2022) l -Asparaginase In Situ Encapsulated into Zwitterionic Nanocapsules with a Prolonged Half-Life . ACS Applied Polymer Materials 4:4, pages 2757-2766.
Crossref
S.S. Alexandrova, Y.A. Gladilina, M.V. Pokrovskaya, N.N. Sokolov & D.D. Zhdanov. (2022) Mechanisms of development of side effects and drug resistance to asparaginase and ways to overcome them. Biomeditsinskaya Khimiya 68:2, pages 104-116.
Crossref
Natalia V. Dobryakova, Dmitry D. Zhdanov, Nikolay N. Sokolov, Svetlana S. Aleksandrova, Marina V. Pokrovskaya & Elena V. Kudryashova. (2022) Improvement of Biocatalytic Properties and Cytotoxic Activity of L-Asparaginase from Rhodospirillum rubrum by Conjugation with Chitosan-Based Cationic Polyelectrolytes. Pharmaceuticals 15:4, pages 406.
Crossref
Tingkai Chen, Tianyu Sun, Yaoyao Bian, Yuqiong Pei, Feng Feng, Heng Chi, Yuan Li, Xu Tang, Shenghu Sang, Chenxi Du, Ying Chen, Yao Chen & Haopeng Sun. (2022) The Design and Optimization of Monomeric Multitarget Peptides for the Treatment of Multifactorial Diseases. Journal of Medicinal Chemistry 65:5, pages 3685-3705.
Crossref
Kexin Fan, Zhan Liu, Min Gao, Kangsheng Tu, Qiuran Xu & Yilei Zhang. (2022) Targeting Nutrient Dependency in Cancer Treatment. Frontiers in Oncology 12.
Crossref
Namrata Chakravarty, Anshu Mathur & R. P. Singh. 2022. Engineered Nanomaterials for Innovative Therapies and Biomedicine. Engineered Nanomaterials for Innovative Therapies and Biomedicine 67 98 .
Yulan Qi, Gina Patel, Joshua Henshaw, Soumi Gupta, Joy Olbertz, Kevin Larimore, Cary O. Harding, Markus Merilainen, Roberto Zori, Nicola Longo, Barbara K. Burton, Mingjin Li, Zhonghua Gu, Stephen J. Zoog, Haoling H. Weng & Becky Schweighardt. (2021) Pharmacokinetic, pharmacodynamic, and immunogenic rationale for optimal dosing of pegvaliase, a PEGylated bacterial enzyme, in adult patients with phenylketonuria. Clinical and Translational Science 14:5, pages 1894-1905.
Crossref
María M Viña-Romero, Ruth Ramos Díaz, Jónathan González García, Gloria Nazco-Casariego, Jésica Díaz-Vera & Fernando Gutiérrez-Nicolás. (2020) Extended enzymatic stability of reconstituted lyophilized PEG-asparaginase in vials. Journal of Oncology Pharmacy Practice 27:5, pages 1102-1105.
Crossref
David O. Riley, Jenna M. Schlefman, Hans Christoph Vitzthum Von Eckstaedt V, Amy L. Morris, Michael K. Keng & Firas El Chaer. (2021) Pegaspargase in Practice: Minimizing Toxicity, Maximizing Benefit. Current Hematologic Malignancy Reports 16:3, pages 314-324.
Crossref
Shunguo Zhang. (2021) Author Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients. Technology in Cancer Research & Treatment 20, pages 153303382110498.
Crossref
Samiran Mukherjee, Prateek S. Harne, Umair Masood, Anuj Sharma & Divey Manocha. (2020) S2703 Matters of the Lymph and the Liver: Transaminitis Associated With PEG-Asparaginase Usage in a Patient With Acute Lymphoblastic Leukemia. American Journal of Gastroenterology 115:1, pages S1414-S1415.
Crossref
Manvi Singh, Nazia Hassan, Devina Verma, Pragya Thakur, Bibhu Prasad Panda, Amulya Kumar Panda, Rakesh Kumar Sharma, Aamir Mirza, Sheikh Mansoor, Salman H. Alrokayan, Haseeb A. Khan, Parvaiz Ahmad & Zeenat Iqbal. (2020) Design of expert guided investigation of native L-asparaginase encapsulated long-acting cross-linker-free poly (lactic-co-glycolic) acid nanoformulation in an Ehrlich ascites tumor model. Saudi Pharmaceutical Journal 28:6, pages 719-728.
Crossref
Guilherme Meira Lima, Brian Effer, Henrique Pellin Biasoto, Veronica Feijoli, Adalberto Pessoa, Giuseppe Palmisano & Gisele Monteiro. (2020) Glycosylation of L-asparaginase from E. coli through yeast expression and site-directed mutagenesis. Biochemical Engineering Journal 156, pages 107516.
Crossref
Marjan Chahardahcherik, Mahboobeh Ashrafi, Younes Ghasemi & Mahmoud Aminlari. (2020) Effect of chemical modification with carboxymethyl dextran on kinetic and structural properties of L-asparaginase. Analytical Biochemistry 591, pages 113537.
Crossref
Lisandra Herrera Belén, Jorge F. Beltrán Lissabet, Carlota de Oliveira Rangel-Yagui, Gisele Monteiro, Adalberto Pessoa & Jorge G. Farías. (2020) Immunogenicity assessment of fungal l-asparaginases: an in silico approach. SN Applied Sciences 2:2.
Crossref
Juan Wu, Changcheng Chen, Shiying Huang, Shuhong Shen, Jing Chen & Shunguo Zhang. (2020) Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln With Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients. Technology in Cancer Research & Treatment 19, pages 153303382098011.
Crossref
Lisandra Herrera Belén, Jorge Beltrán Lissabet, Carlota de Oliveira Rangel-Yagui, Brian Effer, Gisele Monteiro, Adalberto Pessoa & Jorge G. Farías Avendaño. (2019) A structural in silico analysis of the immunogenicity of l-asparaginase from Escherichia coli and Erwinia carotovora. Biologicals 59, pages 47-55.
Crossref
Ninh M. La-Beck, Xinli Liu & Laurence M. Wood. (2019) Harnessing Liposome Interactions With the Immune System for the Next Breakthrough in Cancer Drug Delivery. Frontiers in Pharmacology 10.
Crossref
D. V. Borsakova & E. I. Sinauridze. (2019) L-asparaginase: new approaches to improve pharmacological characteristics. Pediatric Hematology/Oncology and Immunopathology 17:4, pages 82-99.
Crossref
Karol Ciepluch, Aurel Radulescu, Ingo Hoffmann, Andreas Raba, Jürgen Allgaier, Dieter Richter & Ralf Biehl. (2018) Influence of PEGylation on Domain Dynamics of Phosphoglycerate Kinase: PEG Acts Like Entropic Spring for the Protein. Bioconjugate Chemistry 29:6, pages 1950-1960.
Crossref
Robin Rajan, Manoj K. Sabnani, Vikram Mavinkurve, Hilary Shmeeda, Hossein Mansouri, Sandrine Bonkoungou, Alexander D. Le, Laurence M. Wood, Alberto A. Gabizon & Ninh M. La-Beck. (2018) Liposome-induced immunosuppression and tumor growth is mediated by macrophages and mitigated by liposome-encapsulated alendronate. Journal of Controlled Release 271, pages 139-148.
Crossref
Hye-Young Min & Ho-Young Lee. (2018) Oncogene-Driven Metabolic Alterations in Cancer. Biomolecules & Therapeutics 26:1, pages 45-56.
Crossref
Daniel R. Wahl & Sriram Venneti. 2018. Imaging and Metabolism. Imaging and Metabolism 129 154 .
Maristella Maggi, Steven D. Mittelman, Jean Hugues Parmentier, Giorgio Colombo, Massimiliano Meli, Jeannette Marie Whitmire, D. Scott Merrell, Julian Whitelegge & Claudia Scotti. (2017) A protease-resistant Escherichia coli asparaginase with outstanding stability and enhanced anti-leukaemic activity in vitro. Scientific Reports 7:1.
Crossref
Peng-Peng Xu, Jie Xiong, Shu Cheng, Xia Zhao, Chao-Fu Wang, Gang Cai, Hui-Juan Zhong, Heng-Ye Huang, Jia-Yi Chen & Wei-Li Zhao. (2017) A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type. EBioMedicine 25, pages 41-49.
Crossref
Ali Ghasemi, Sedigheh Asad, Mahboubeh Kabiri & Bahareh Dabirmanesh. (2017) Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent. Applied Microbiology and Biotechnology 101:19, pages 7227-7238.
Crossref
Sathish Dyawanapelly, Nishant Kumar Jain, Sindhu KR, Maruthi Prasanna & Akhilesh Vikram Singh. 2017. Handbook of Composites from Renewable Materials. Handbook of Composites from Renewable Materials 483 541 .
Ahmet Ulu & Burhan Ates. (2017) Immobilization of l -Asparaginase on Carrier Materials: A Comprehensive Review . Bioconjugate Chemistry 28:6, pages 1598-1610.
Crossref
Mahdieh Mahboobi, Hamid Sedighian, Mojtaba Hedayati CH, Bijan Bambai, Saeed Esmaeil Soofian & Jafar Amani. (2017) Applying Bioinformatic Tools for Modeling and Modifying Type II E. coli l-Asparginase to Present a Better Therapeutic Agent/Drug for Acute Lymphoblastic Leukemia. International Journal of Cancer Management 10:3.
Crossref
João H. P. M. Santos, Iris M. Costa, João V. D. Molino, Mariana S. M. Leite, Marcela V. Pimenta, João A. P. Coutinho, Adalberto PessoaJrJr, Sónia P. M. Ventura, André M. Lopes & Gisele Monteiro. (2017) Heterologous expression and purification of active L-asparaginase I of Saccharomyces cerevisiae in Escherichia coli host . Biotechnology Progress 33:2, pages 416-424.
Crossref
Simone Hearps, Marc Seal, Vicki Anderson, Maria McCarthy, Madeleine Connellan, Peter Downie & Cinzia De Luca. (2017) The relationship between cognitive and neuroimaging outcomes in children treated for acute lymphoblastic leukemia with chemotherapy only: A systematic review. Pediatric Blood & Cancer 64:2, pages 225-233.
Crossref
João H. P. M. Santos, Gustavo Carretero, João A. P. Coutinho, Carlota O. Rangel-Yagui & Sónia P. M. Ventura. (2017) Multistep purification of cytochrome c PEGylated forms using polymer-based aqueous biphasic systems. Green Chemistry 19:24, pages 5800-5808.
Crossref
Ana Tinoco, Artur Ribeiro, César Oliveira, Pier Parpot, Andreia Gomes & Artur Cavaco-Paulo. (2016) Albumin/asparaginase capsules prepared by ultrasound to retain ammonia. Applied Microbiology and Biotechnology 100:22, pages 9499-9508.
Crossref
Xavier Thomas & Caroline Le Jeune. (2016) Erythrocyte encapsulated l -asparaginase (GRASPA) in acute leukemia . International Journal of Hematologic Oncology 5:1, pages 11-25.
Crossref
Abhinav Shrivastava, Abdul Arif Khan, Mohsin Khurshid, Mohd Abul Kalam, Sudhir K. Jain & Pradeep K. Singhal. (2016) Recent developments in l-asparaginase discovery and its potential as anticancer agent. Critical Reviews in Oncology/Hematology 100, pages 1-10.
Crossref
Qi-Ying Hu, Francesco Berti & Roberto Adamo. (2016) Towards the next generation of biomedicines by site-selective conjugation. Chemical Society Reviews 45:6, pages 1691-1719.
Crossref
Junxiao Ye, Meong Cheol Shin, Qiuling Liang, Huining He & Victor C. Yang. (2015) 15 years of ATTEMPTS: A macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting. Journal of Controlled Release 205, pages 58-69.
Crossref
Dandan Luo, Kevin A. Carter & Jonathan F. Lovell. (2014) Nanomedical engineering: shaping future nanomedicines. WIREs Nanomedicine and Nanobiotechnology 7:2, pages 169-188.
Crossref
Da Hye YoonSung Hee KangHwan Soo Kim, Jae Wook LeeJong-Seo YoonNack Gyun ChungBin Cho. (2015) Effectiveness of premedication and rapid desensitization in hypersensitivity to L-asparaginase. Allergy, Asthma & Respiratory Disease 3:4, pages 288.
Crossref
Mi Liu, Pål Johansen, Franziska Zabel, Jean-Christophe Leroux & Marc A. Gauthier. (2014) Semi-permeable coatings fabricated from comb-polymers efficiently protect proteins in vivo. Nature Communications 5:1.
Crossref
Shaohua Zuo, Dong Xue, Tao Zhang, Bo Jiang & Wanmeng Mu. (2014) Biochemical characterization of an extremely thermostable l-asparaginase from Thermococcus gammatolerans EJ3. Journal of Molecular Catalysis B: Enzymatic 109, pages 122-129.
Crossref
Jitesh D. Kawedia & Michael E. Rytting. (2014) Asparaginase in Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma and Leukemia 14, pages S14-S17.
Crossref
Betiana Felice, Molamma P. Prabhakaran, Andrea P. Rodríguez & Seeram Ramakrishna. (2014) Drug delivery vehicles on a nano-engineering perspective. Materials Science and Engineering: C 41, pages 178-195.
Crossref
Huining He, Junxiao Ye, Yinsong Wang, Quan Liu, Hee Sun Chung, Young Min Kwon, Meong Cheol Shin, Kyuri Lee & Victor C. Yang. (2014) Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application. Journal of Controlled Release 176, pages 123-132.
Crossref
Rajesh A. Shenoi, Fang Gao, Muhammad Imran Ul-Haq & Jayachandran N. Kizhakkedathu. 2014. Chemistry of Bioconjugates. Chemistry of Bioconjugates 77 103 .
Augusto F. AndradeKleiton S. BorgesVanessa S. Silveira. (2014) Update on the Use of L-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia. Clinical Medicine Insights: Oncology 8, pages CMO.S10242.
Crossref
C. Moscardó Guilleme, R. Fernández Delgado, J. Sevilla Navarro, I. Astigarraga Aguirre, S. Rives Solà, J. Sánchez de Toledo Codina, J.L. Fuster Soler, L. Parra Ramirez, J. Molina Garicaño, B. González Martínez & L. Madero López. (2013) Actualización del tratamiento con L-asparraginasa en Pediatría. Anales de Pediatría 79:5, pages 329.e1-329.e11.
Crossref
N. S. Mohan Kumar & H. K. Manonmani. (2012) Purification, characterization and kinetic properties of extracellular l-asparaginase produced by Cladosporium sp.. World Journal of Microbiology and Biotechnology 29:4, pages 577-587.
Crossref
Mario I. Ortiz, Sandra Rivera-Roldán, Marco A. Escamilla-Acosta, Georgina Romo-Hernández, Héctor A. Ponce-Monter & Rita Escárcega-Ángeles. (2013) Side Effects of Vincristine and L-Asparaginase in Patients with Acute Lymphoblastic Leukemia in a Mexican Pediatric Hospital. Pharmacology & Pharmacy 04:03, pages 347-354.
Crossref
Ankit P. Sudhir, Bhaumik R. Dave, Kalkal A. Trivedi & Ramalingam B. Subramanian. (2012) Production and amplification of an l-asparaginase gene from actinomycete isolate Streptomyces ABR2. Annals of Microbiology 62:4, pages 1609-1614.
Crossref
Jason R. Cantor, Vasiliki Panayiotou, Giulia Agnello, George Georgiou & Everett M. Stone. 2012. Protein Engineering for Therapeutics, Part A. Protein Engineering for Therapeutics, Part A 291 319 .
Raphaële R.L. van Litsenburg, Carin A. Uyl‐de Groot, Hein Raat, Gertjan J.L. Kaspers & Reinoud J.B.J. Gemke. (2011) Cost‐effectiveness of treatment of childhood acute lymphoblastic leukemia with chemotherapy only: The influence of new medication and diagnostic technology. Pediatric Blood & Cancer 57:6, pages 1005-1010.
Crossref
Nadine Eisele, Diana Linke, Katrin Bitzer, Shukry Na’amnieh, Manfred Nimtz & Ralf G. Berger. (2011) The first characterized asparaginase from a basidiomycete, Flammulina velutipes. Bioresource Technology 102:3, pages 3316-3321.
Crossref
Rob Pieters, Stephen P. Hunger, Joachim Boos, Carmelo Rizzari, Lewis Silverman, Andre Baruchel, Nicola Goekbuget, Martin Schrappe & Ching‐Hon Pui. (2010) L‐asparaginase treatment in acute lymphoblastic leukemia. Cancer 117:2, pages 238-249.
Crossref
Elizabeth A. Raetz & Wanda L. Salzer. (2010) Tolerability and Efficacy of L-Asparaginase Therapy in Pediatric Patients With Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 32:7, pages 554-563.
Crossref
X. Thomas, G. Cannas, Y. Chelghoum & A. Gougounon. (2010) Alternatives thérapeutiques à la L-asparaginase native dans le traitement de la leucémie aiguë lymphoblastique de l'adulte. Bulletin du Cancer 97:9, pages 1105-1117.
Crossref
Christine Chordas & Kristen Graham. 2010. Pediatric Oncology Nursing. Pediatric Oncology Nursing 203 232 .
Eugenia Teodor, Simona-Carmen Litescu, Veronica Lazar & Raluca Somoghi. (2009) Hydrogel-magnetic nanoparticles with immobilized l-asparaginase for biomedical applications. Journal of Materials Science: Materials in Medicine 20:6, pages 1307-1314.
Crossref
Ozge Uysal Soyer, Selin Aytac, Ayfer Tuncer, Mualla Cetin, Sevgi Yetgin & Bulent Enis Sekerel. (2009) Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia. Journal of Allergy and Clinical Immunology 123:4, pages 895-899.
Crossref
Rory F. Finn. 2009. PEGylated Protein Drugs: Basic Science and Clinical Applications. PEGylated Protein Drugs: Basic Science and Clinical Applications 187 203 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.